FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3201553630> ?p ?o ?g. }

• W3201553630 endingPage "e0257283" @default.
• W3201553630 startingPage "e0257283" @default.
• W3201553630 abstract "Background Caudal epidural block (CEB) provides reliable anesthesia for adults undergoing anorectal surgery. Despite the widely utilization, the minimum effective concentration for 90% patients (MEC 90 ) of ropivacaine for CEB remains unknown. Objective To estimate MEC of ropivacaine for CEB in anorectal surgery. Design A prospective dose-finding study using biased coin design up-and-down sequential method. Setting Operating room and postoperative recovery area of Chengdu Shangjin Nanfu Hospital, from October 2019 to January 2020. Patients 50 males and 51 females scheduled for anorectal surgery. Interventions We conducted two independent biased coin design up-and down trials by genders. The concentration of ropivacaine administered to the first patient of male and female were 0.25% with fixed volume of 14ml for male and 12ml for female patients based on our previous study. In case of failure, the concentration was increased by 0.05% in the next subject. Otherwise, the next subject was randomized to a concentration 0.05% less with a probability of 0.11, or the same concentration with a probability of 0.89. Success was defined as complete sensory blockade of perineal area 15 min after the block evidenced by the presence of a lax anal sphincter and pain-free surgery. Main outcome measures The MEC of ropivacaine to achieve a successful CEB in 90%(MEC 90 ) of the patients. Results The MEC 90 of ropivacaine for CEB were estimated to be 0.35% (95% CI 0.29 to 0.4%) for male and 0.353% (95%CI 0.22 to 0.4%) for female. By extrapolation to MEC in 99% of subjects (MEC99) and pooled adjacent violators algorithm (PAVA) adjusted responses, it would be optimal to choose 0.4% ropivacaine with a volume of 14ml for male and 12ml for female. Conclusions A concentration of 0.35% ropivacaine with a volume of 14ml provided a successful CEB in 90% of the male patients, while 0.353% ropivacaine with a volume of 12ml provided a successful CEB in 90% of the female patients. A concentration of 0.4% and a volume of 14ml for male and 12 ml for female would be successful in 99% of the patients. Trial registration Chictr.org.cn identifier: No. ChiCTR 1900024315." @default.
• W3201553630 created "2021-09-27" @default.
• W3201553630 creator A5000551546 @default.
• W3201553630 creator A5002534088 @default.
• W3201553630 creator A5008397523 @default.
• W3201553630 creator A5023485142 @default.
• W3201553630 creator A5026421584 @default.
• W3201553630 creator A5027835055 @default.
• W3201553630 creator A5075945214 @default.
• W3201553630 date "2021-09-17" @default.
• W3201553630 modified "2023-10-16" @default.
• W3201553630 title "The minimum effective concentration (MEC90) of ropivacaine for ultrasound-guided caudal block in anorectal surgery. A dose finding study" @default.
• W3201553630 cites W1485450669 @default.
• W3201553630 cites W1659031623 @default.
• W3201553630 cites W1964983175 @default.
• W3201553630 cites W1965504547 @default.
• W3201553630 cites W1966235019 @default.
• W3201553630 cites W1966424334 @default.
• W3201553630 cites W1977951060 @default.
• W3201553630 cites W1988025736 @default.
• W3201553630 cites W1994016568 @default.
• W3201553630 cites W2007365090 @default.
• W3201553630 cites W2011023179 @default.
• W3201553630 cites W2015474709 @default.
• W3201553630 cites W2016643416 @default.
• W3201553630 cites W2043144545 @default.
• W3201553630 cites W2049876585 @default.
• W3201553630 cites W2060139672 @default.
• W3201553630 cites W2062565171 @default.
• W3201553630 cites W2066767352 @default.
• W3201553630 cites W2071659959 @default.
• W3201553630 cites W2087907143 @default.
• W3201553630 cites W2098939860 @default.
• W3201553630 cites W2142580207 @default.
• W3201553630 cites W2153760622 @default.
• W3201553630 cites W2171999085 @default.
• W3201553630 cites W2325625923 @default.
• W3201553630 cites W2554920634 @default.
• W3201553630 cites W2613435235 @default.
• W3201553630 cites W2758378951 @default.
• W3201553630 cites W2784006874 @default.
• W3201553630 cites W2805706526 @default.
• W3201553630 cites W2912276325 @default.
• W3201553630 doi "https://doi.org/10.1371/journal.pone.0257283" @default.
• W3201553630 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8448308" @default.
• W3201553630 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34534232" @default.
• W3201553630 hasPublicationYear "2021" @default.
• W3201553630 type Work @default.
• W3201553630 sameAs 3201553630 @default.
• W3201553630 citedByCount "3" @default.
• W3201553630 countsByYear W32015536302022 @default.
• W3201553630 countsByYear W32015536302023 @default.
• W3201553630 crossrefType "journal-article" @default.
• W3201553630 hasAuthorship W3201553630A5000551546 @default.
• W3201553630 hasAuthorship W3201553630A5002534088 @default.
• W3201553630 hasAuthorship W3201553630A5008397523 @default.
• W3201553630 hasAuthorship W3201553630A5023485142 @default.
• W3201553630 hasAuthorship W3201553630A5026421584 @default.
• W3201553630 hasAuthorship W3201553630A5027835055 @default.
• W3201553630 hasAuthorship W3201553630A5075945214 @default.
• W3201553630 hasBestOaLocation W32015536301 @default.
• W3201553630 hasConcept C126894567 @default.
• W3201553630 hasConcept C141071460 @default.
• W3201553630 hasConcept C168563851 @default.
• W3201553630 hasConcept C2777399655 @default.
• W3201553630 hasConcept C2780035688 @default.
• W3201553630 hasConcept C2780269707 @default.
• W3201553630 hasConcept C2781074409 @default.
• W3201553630 hasConcept C2781102422 @default.
• W3201553630 hasConcept C42219234 @default.
• W3201553630 hasConcept C71924100 @default.
• W3201553630 hasConceptScore W3201553630C126894567 @default.
• W3201553630 hasConceptScore W3201553630C141071460 @default.
• W3201553630 hasConceptScore W3201553630C168563851 @default.
• W3201553630 hasConceptScore W3201553630C2777399655 @default.
• W3201553630 hasConceptScore W3201553630C2780035688 @default.
• W3201553630 hasConceptScore W3201553630C2780269707 @default.
• W3201553630 hasConceptScore W3201553630C2781074409 @default.
• W3201553630 hasConceptScore W3201553630C2781102422 @default.
• W3201553630 hasConceptScore W3201553630C42219234 @default.
• W3201553630 hasConceptScore W3201553630C71924100 @default.
• W3201553630 hasFunder F4320321001 @default.
• W3201553630 hasIssue "9" @default.
• W3201553630 hasLocation W32015536301 @default.
• W3201553630 hasLocation W32015536302 @default.
• W3201553630 hasLocation W32015536303 @default.
• W3201553630 hasLocation W32015536304 @default.
• W3201553630 hasOpenAccess W3201553630 @default.
• W3201553630 hasPrimaryLocation W32015536301 @default.
• W3201553630 hasRelatedWork W2083485027 @default.
• W3201553630 hasRelatedWork W2088127183 @default.
• W3201553630 hasRelatedWork W2105933214 @default.
• W3201553630 hasRelatedWork W2319020390 @default.
• W3201553630 hasRelatedWork W2515733501 @default.
• W3201553630 hasRelatedWork W2594633972 @default.
• W3201553630 hasRelatedWork W2624028630 @default.
• W3201553630 hasRelatedWork W3201553630 @default.
• W3201553630 hasRelatedWork W4238986311 @default.

• next